Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.14365/5965
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBolek, H.-
dc.contributor.authorKuzu, O.F.-
dc.contributor.authorSertesen Camoz, E.-
dc.contributor.authorSim, S.-
dc.contributor.authorSekmek, S.-
dc.contributor.authorKarakas, H.-
dc.contributor.authorUrun, Y.-
dc.date.accessioned2025-02-25T19:32:16Z-
dc.date.available2025-02-25T19:32:16Z-
dc.date.issued2025-
dc.identifier.issn2523-3548-
dc.identifier.urihttps://doi.org/10.1002/cac2.70003-
dc.identifier.urihttps://hdl.handle.net/20.500.14365/5965-
dc.language.isoenen_US
dc.publisherJohn Wiley and Sons Incen_US
dc.relation.ispartofCancer Communicationsen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleSunitinib in Metastatic Renal Cell Carcinoma: Clinical Outcomes Across Risk Groups in a Turkish Oncology Group Kidney Cancer Consortiumen_US
dc.typeLetteren_US
dc.identifier.doi10.1002/cac2.70003-
dc.identifier.scopus2-s2.0-85217359773-
dc.departmentİzmir Ekonomi Üniversitesien_US
dc.authorscopusid57211652341-
dc.authorscopusid59150821900-
dc.authorscopusid59547302000-
dc.authorscopusid59481213500-
dc.authorscopusid57226085393-
dc.authorscopusid58716740900-
dc.authorscopusid57203683804-
dc.relation.publicationcategoryDiğeren_US
dc.identifier.scopusqualityQ1-
dc.identifier.wosqualityQ1-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeLetter-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.languageiso639-1en-
item.grantfulltextnone-
Appears in Collections:Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Show simple item record



CORE Recommender

Page view(s)

28
checked on Apr 14, 2025

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.